Bokf Na Has $84,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Bokf Na trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,936 shares of the pharmacy operator’s stock after selling 1,171 shares during the period. Bokf Na’s holdings in Walgreens Boots Alliance were worth $84,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in WBA. Iron Horse Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares during the last quarter. Pineridge Advisors LLC acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at $26,000. Blue Trust Inc. boosted its position in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares during the period. Quest Partners LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at about $30,000. Finally, Continuum Advisory LLC boosted its position in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Bank of America reduced their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research report on Friday, June 28th. Finally, Evercore ISI cut their price objective on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research report on Friday, June 28th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $14.73.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $9.06 on Wednesday. The business has a 50 day moving average of $10.44 and a 200-day moving average of $14.93. Walgreens Boots Alliance, Inc. has a 1 year low of $8.46 and a 1 year high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. The company has a market capitalization of $7.82 billion, a P/E ratio of -1.34, a P/E/G ratio of 0.98 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The firm had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.00 EPS. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 11.04%. The ex-dividend date of this dividend was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.